![Peter Dudek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Dudek
Presidente presso Merck Research Ventures
Posizioni attive di Peter Dudek
Società | Posizione | Inizio | Fine |
---|---|---|---|
Merck Research Ventures
![]() Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Investitore di Private Equity | 01/04/2018 | - |
Presidente | 01/03/2021 | - | |
Ambagon Therapeutics, Inc.
![]() Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 01/07/2020 | - |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Direttore/Membro del Consiglio | 01/12/2020 | - |
InduPro, Inc.
![]() InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Direttore/Membro del Consiglio | 01/02/2022 | - |
Caraway Therapeutics, Inc.
![]() Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/11/2021 | - |
Tallac Therapeutics, Inc.
![]() Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Direttore/Membro del Consiglio | 01/11/2021 | - |
Storia della carriera di Peter Dudek
Precedenti posizioni note di Peter Dudek
Società | Posizione | Inizio | Fine |
---|---|---|---|
Xilio Therapeutics LLC
![]() Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Direttore/Membro del Consiglio | 01/12/2019 | 01/02/2021 |
Wellington Partners GmbH
![]() Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investitore di Private Equity | 01/02/2016 | 31/03/2018 |
Entrepreneurs Fund Management LLP
![]() Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund Management LLP (Entrepreneurs Fund) is a venture capital subsidiary of Bellefontaine Investments AG founded in 2002. The firm is headquartered in London, the United kingdom. | Analista di Private Equity | 01/05/2011 | 01/01/2016 |
Formazione di Peter Dudek
University of British Columbia | Undergraduate Degree |
University of Geneva | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Germania | 2 |
Canada | 2 |
Posizioni
Director/Board Member | 6 |
Private Equity Investor | 2 |
Private Equity Analyst | 1 |
Settori
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 9 |
---|---|
Wellington Partners GmbH
![]() Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Entrepreneurs Fund Management LLP
![]() Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund Management LLP (Entrepreneurs Fund) is a venture capital subsidiary of Bellefontaine Investments AG founded in 2002. The firm is headquartered in London, the United kingdom. | Finance |
Merck Research Ventures
![]() Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Caraway Therapeutics, Inc.
![]() Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA. | Health Technology |
Tallac Therapeutics, Inc.
![]() Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Health Technology |
Ambagon Therapeutics, Inc.
![]() Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Health Technology |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Health Technology |
Xilio Therapeutics LLC
![]() Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Health Technology |
InduPro, Inc.
![]() InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Health Technology |
- Borsa valori
- Insiders
- Peter Dudek
- Esperienza